HomeBIOBV • HEL
add
Biohit Oyj
Previous close
€3.00
Day range
€2.86 - €2.94
Year range
€1.87 - €4.35
Market cap
36.50M EUR
Avg Volume
49.78K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.45M | 4.93% |
Operating expense | 1.70M | -3.93% |
Net income | 700.00K | 210.42% |
Net profit margin | 20.29 | 195.77% |
Earnings per share | — | — |
EBITDA | 700.00K | 124.00% |
Effective tax rate | 6.67% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.70M | -1.67% |
Total assets | 15.50M | 19.97% |
Total liabilities | 3.30M | -5.55% |
Total equity | 12.20M | — |
Shares outstanding | 15.18M | — |
Price to book | 3.75 | — |
Return on assets | 10.48% | — |
Return on capital | 12.70% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 700.00K | 210.42% |
Cash from operations | 1.05M | 61.29% |
Cash from investing | 50.00K | 8.70% |
Cash from financing | -50.00K | -1.01% |
Net change in cash | 950.00K | 45.59% |
Free cash flow | 325.00K | 362.22% |
About
Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care. Wikipedia
Founded
1988
Website
Employees
46
